RTW Biotech Opportunities Ltd
RTWFF
$1.64
$0.2820.59%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 35.11M | 21.65M | 8.19M | 6.67M | 5.16M |
| Total Revenue | 35.11M | 21.65M | 8.19M | 6.67M | 5.16M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 35.11M | 21.65M | 8.19M | 6.67M | 5.16M |
| SG&A Expenses | 12.30M | 11.80M | 11.31M | 9.95M | 8.59M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.48M | 12.82M | 12.16M | 10.66M | 9.16M |
| Operating Income | 21.63M | 8.83M | -3.97M | -3.99M | -4.00M |
| Income Before Tax | -92.38M | -29.10M | 34.18M | 85.35M | 136.53M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -92.38 | -29.10 | 34.18 | 85.35 | 136.53 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -92.38M | -29.10M | 34.18M | 85.35M | 136.53M |
| EBIT | 21.63M | 8.83M | -3.97M | -3.99M | -4.00M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.28 | -0.09 | 0.10 | 0.30 | 0.50 |
| Normalized Basic EPS | -0.02 | 0.03 | 0.08 | 0.08 | 0.09 |
| EPS Diluted | -0.28 | -0.09 | 0.10 | 0.30 | 0.50 |
| Normalized Diluted EPS | -0.02 | 0.03 | 0.08 | 0.08 | 0.09 |
| Average Basic Shares Outstanding | 1.33B | 1.34B | 1.34B | 1.22B | 1.09B |
| Average Diluted Shares Outstanding | 1.33B | 1.34B | 1.34B | 1.22B | 1.09B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |